N. Tableau, N : Système nerveux. L'index PBT correspond à la somme de : P (persistance), B (bioaccumulation), T (toxicité) ; L'astérix (*) pouvant figurer sur l'index PBT indique que l'évaluation est incertaine en raison d'un manque de données

. Ainsi-parmi-c, est 18 PA, 6 PA présentent un index PBT au maximum à 9. Il s'agit d'un antiparkinsonien : la bromocriptine (parlodel®, bromokin®); d'un psycholeptique utilisé dans le cadre du traitement de la schizophrénie: la clozapine (leponex®)

C. Hignite and D. Azarnoff, Drugs and drug metabolites as environmental contaminants: Chlorophenoxyisobutyrate and salicylic acid in sewage water effluent, Life Sciences, vol.20, issue.2, pp.337-378, 1977.
DOI : 10.1016/0024-3205(77)90329-0

S. Jorgensen and B. Halling-sorensen, Drugs in the environment, Chemosphere, vol.40, issue.7, 2000.
DOI : 10.1016/S0045-6535(99)00438-5

J. Dorne, L. Skinner, G. Frampton, D. Spurgeon, and A. Ragas, Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology, Analytical and Bioanalytical Chemistry, vol.12, issue.Suppl 6, pp.1259-68, 2007.
DOI : 10.1289/ehp.6674

D. Bendz, N. Paxeus, T. Ginn, and F. Loge, Occurrence and fate of pharmaceutically active compounds in the environment, a case study: H??je River in Sweden, Journal of Hazardous Materials, vol.122, issue.3, pp.195-204, 2005.
DOI : 10.1016/j.jhazmat.2005.03.012

M. Carballa, F. Omil, J. Lema, M. Llompart, C. Garcia-jares et al., Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, Water Research, vol.38, issue.12, pp.2918-2944, 2004.
DOI : 10.1016/j.watres.2004.03.029

A. Joss, E. Keller, A. Alder, A. Gobel, C. Mcardell et al., Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Research, vol.39, issue.14, 2005.
DOI : 10.1016/j.watres.2005.05.031

K. Kummerer, Drugs, diagnostic agents and disinfectants in wastewater and water--a review, Schriftenr Ver Wasser Boden Lufthyg, vol.105, pp.59-71, 2000.

T. Heberer, Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data, Toxicology Letters, vol.131, issue.1-2, pp.5-17, 2002.
DOI : 10.1016/S0378-4274(02)00041-3

C. Carlsson, A. Johansson, G. Alvan, K. Bergman, T. Kuhler et al., Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ-3):67-87. 10. L'Eau: Enjeux et perspectives de recherche Ministèredélégué à l'enseignement supérieur et à la recherche The Milwaukee Cryptosporidium outbreak: assessment of incubation time and daily attack rate, 1_110. 11, pp.59-69, 2004.

C. Clark, L. Price, R. Ahmed, D. Woodward, P. Melito et al., Characterization of waterborne outbreak-associated Campylobacter jejuni 13. Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry, Walkerton, Ontario. Emerg Infect Dis. J Chromatogr A, vol.9107938, issue.1012, pp.1232-41175, 1999.

N. Kosciusko-morizet, Santé Environnement-2eme plan national, 20092013.

P. Houeto, Réglementation et évaluation du risque environnemental des médicaments à usage humain Résidus de médicaments dans l'eau: des molécules à surveiller? des risques à évaluer? amphithéatre Larroque, Paris 7ème Bound JP, Voulvoulis N. Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United kingdom Environ Health Perspect, Ministère de la Santé dlJ, des Sports et de la Vie associative, pp.1-21, 2005.

T. Budzinski, E. Zuccato, D. Calamari, M. Natangelo, and R. Fanelli, Présence des résidus de médicaments dans différents compartiments du milieu aquatique Presence of therapeutic drugs in the environment, Environnement Risque Santé. Lancet, vol.5355, issue.239217, pp.248-531789, 2000.

S. Weigel, U. Berger, E. Jensen, R. Kallenborn, H. Thoresen et al., Determination of selected pharmaceuticals and caffeine in sewage and seawater from Troms??/Norway with emphasis on ibuprofen and its metabolites, Chemosphere, vol.56, issue.6, 2004.
DOI : 10.1016/j.chemosphere.2004.04.015

F. Cabello, Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment, Environmental Microbiology, vol.112, issue.7, 2006.
DOI : 10.1016/S0924-8579(00)00301-0

O. Jones, J. Lester, and N. Voulvoulis, Pharmaceuticals: a threat to drinking water? Trends Biotechnol, pp.163-170, 2005.
DOI : 10.1016/j.tibtech.2005.02.001

H. Fenet, Transformation des médicaments après rejet dans le milieu aquatique

L. Ministère-de, . Santé, T. Crisp, E. Clegg, R. Cooper et al., Résidus de médicaments dans l'eau: des molécules à surveiller? des risques à évaluer? Amphithéâtre Larroque Paris 7ème Environment and Pharmaceuticals: Apoteket AB; (The National Corporation of Swedish Pharmacies), Stockholm County; Council and Stockholm University 2006. 29. Hartemann P. Eau: Comment traiter les micropolluants? fondapol: fondation pour l'innovation politique Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect, Feb, vol.28106, issue.30 1, pp.1-21, 1998.

F. Giuliani, T. Koller, F. Wurgler, and R. Widmer, Detection of genotoxic activity in native hospital waste water by the umuC test, Mutation Research/Genetic Toxicology, vol.368, issue.1, pp.49-57, 1996.
DOI : 10.1016/S0165-1218(96)90039-7

R. Laenge, T. Steger-hartmann, and H. Schweinfurth, The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process, Regulatory Toxicology and Pharmacology, vol.45, issue.3, pp.223-231, 2006.
DOI : 10.1016/j.yrtph.2006.04.001

S. N. Lagerlöf and . Holgerssons-underbara-resa-genom-sverige, 1906-1907. 36. L'agence suédoise pour la protection de l'environnement / Naturvårdsverket Mise à jour le 14 juin Programme de l'OCDE sur l'environnement: examen environnemental de la Suède.6. 38. Wennmalm A, Gunnarsson B. Pharmaceutical management through environmental product labeling in Sweden, 40. Santé AFdSSdPd. Les ventes de médicaments aux officines et aux hôpitaux en France, pp.775-782, 2005.

. Chiffres-clés, 41 Protection IfHaC Technical Guidance Document on Risk Assessment European Commission joint research centreTGD part I. 42. commission e. Technical Guidance Document in Risk Assessment. Institute for Health and Consumer Protection European Chemicals Bureau (ECB).part II:337. 43. FASS. Environmental classification of pharmaceuticals in www.fass.se, 1999.

/. Janvier and . Fevrier, Raphaël Chaussénéry PG. Le service d'assainissement en France: principales données 2008. Service de l'observation et des statistiques, pp.8-118, 1999.